3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pain, Postoperative
18
Breast Neoplasms
14
Pain
5
Lung Neoplasms
5
Neoplasms
3
Agnosia
3
Thyroid Nodule
2
Thyroid Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Goiter
2
Colorectal Neoplasms
2
Chronic Pain
2
Breast Cancer Female
2
Abdominal Cancer
2
post laminectomy syndrome
1
Uterine Cervical Dysplasia
1
Supratentorial Neoplasms
1
Stomach Neoplasms
1
Respiration Disorders
1
Reperfusion Injury
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Peritoneal Cancer
1
Neuroma
1
Neuralgia
1
Mucositis
1
Liver Neoplasms
1
Leiomyoma
1
Laryngeal Neoplasms
1
Interventions
Infliximab
3
Tea
2
Polyethylene Glycols
2
Lidocaine
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
sodium phosphate
1
purine
1
prucalopride
1
picosulfate sodium
1
golimumab
1
fumaric acid
1
Sulfasalazine
1
Pneumococcal Vaccines
1
Passive Cutaneous Anaphylaxis
1
Papillomavirus Vaccines
1
Narrow Band Imaging
1
Morphine
1
Methotrexate
1
Mesalamine
1
Mercaptopurine
1
MEDI2070
1
Exercise
1
Etanercept
1
Dietary Supplements
1
Diatrizoate Meglumine
1
Diagnostic Imaging
1
Calcium Dobesilate
1
CT-P13
1
Bupivacaine
1
Bisacodyl
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Inflammatory Bowel Diseases
×
Bupivacaine
×
Clear all
NCT03723447
2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4
Completed
102 enrolled
9 charts